These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36895941)

  • 21. Combined pharmacophore modeling, docking, and 3D-QSAR studies of PLK1 inhibitors.
    Lu S; Liu HC; Chen YD; Yuan HL; Sun SL; Gao YP; Yang P; Zhang L; Lu T
    Int J Mol Sci; 2011; 12(12):8713-39. PubMed ID: 22272100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D-QSAR and docking studies on 4-anilinoquinazoline and 4-anilinoquinoline epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors.
    Assefa H; Kamath S; Buolamwini JK
    J Comput Aided Mol Des; 2003 Aug; 17(8):475-93. PubMed ID: 14703120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2D and 3D-QSAR analysis of pyrazole-thiazolinone derivatives as EGFR kinase inhibitors by CoMFA and CoMSIA.
    Pourbasheer E; Aalizadeh R; Shiri HM; Banaei A; Ganjali MR
    Curr Comput Aided Drug Des; 2015; 11(4):292-303. PubMed ID: 26548551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 3D-QSAR, molecular docking, DFT and ADMET studies on quinazoline derivatives to explore novel DHFR inhibitors.
    Hadni H; Bakhouch M; Elhallaoui M
    J Biomol Struct Dyn; 2023 Jan; 41(1):161-175. PubMed ID: 34825630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure based 3D-QSAR studies of Interleukin-2 inhibitors: Comparing the quality and predictivity of 3D-QSAR models obtained from different alignment methods and charge calculations.
    Halim SA; Zaheer-ul-Haq
    Chem Biol Interact; 2015 Aug; 238():9-24. PubMed ID: 26051521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined 3D-QSAR modeling and molecular docking study on 1,4-dihydroindeno[1,2-c]pyrazoles as VEGFR-2 kinase inhibitors.
    Zeng H; Zhang H
    J Mol Graph Model; 2010 Aug; 29(1):54-71. PubMed ID: 20471293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modification of polychlorinated phenols and evaluation of their toxicity, biodegradation and bioconcentration using three-dimensional quantitative structure-activity relationship models.
    Tong L; Guo L; Lv X; Li Y
    J Mol Graph Model; 2017 Jan; 71():1-12. PubMed ID: 27825025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. QSAR Research of Novel Tetrandrine Derivatives against Human Hepatocellular Carcinoma.
    Wang M; Qiu B; Wang W; Li X; Huo H
    Anticancer Agents Med Chem; 2023; 23(19):2146-2153. PubMed ID: 37653634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular Modeling Study for the Design of Novel Peroxisome Proliferator-Activated Receptor Gamma Agonists using 3D-QSAR and Molecular Docking.
    Jian Y; He Y; Yang J; Han W; Zhai X; Zhao Y; Li Y
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29473866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the Structural Features of Guanine Derivatives as MGMT Inhibitors Using 3D-QSAR Modeling Combined with Molecular Docking.
    Sun G; Fan T; Zhang N; Ren T; Zhao L; Zhong R
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploration of 3,6-dihydroimidazo(4,5-d)pyrrolo(2,3-b)pyridin-2(1H)-one derivatives as JAK inhibitors using various in silico techniques.
    Jisha RS; Aswathy L; Masand VH; Gajbhiye JM; Shibi IG
    In Silico Pharmacol; 2017; 5():9. PubMed ID: 29085766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 3D-QSAR studies on CCR2B receptor antagonists: Insight into the structural requirements of (R)-3-aminopyrrolidine series of molecules based on CoMFA/CoMSIA models.
    Gade S; Mahmood S
    J Pharm Bioallied Sci; 2012 Apr; 4(2):123-33. PubMed ID: 22557923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico evaluation, molecular docking and QSAR analysis of quinazoline-based EGFR-T790M inhibitors.
    Asadollahi-Baboli M
    Mol Divers; 2016 Aug; 20(3):729-39. PubMed ID: 27209475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR modeling and in silico design of small-molecule inhibitors targeting the interaction between E3 ligase VHL and HIF-1α.
    Pan J; Zhang Y; Ran T; Xu A; Qiao X; Yin L; Zhou W; Zhu L; Zhao J; Lu T; Chen Y; Jiang Y
    Mol Divers; 2017 Aug; 21(3):719-739. PubMed ID: 28689235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies.
    Hou T; Zhu L; Chen L; Xu X
    J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparative QSAR studies on peptide deformylase inhibitors.
    Lee JY; Doddareddy MR; Cho YS; Choo H; Koh HY; Kang JH; No KT; Pae AN
    J Mol Model; 2007 May; 13(5):543-58. PubMed ID: 17333308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 3D MI-DRAGON: new model for the reconstruction of US FDA drug- target network and theoretical-experimental studies of inhibitors of rasagiline derivatives for AChE.
    Prado-Prado F; García-Mera X; Escobar M; Alonso N; Caamaño O; Yañez M; González-Díaz H
    Curr Top Med Chem; 2012; 12(16):1843-65. PubMed ID: 23030618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative structure-activity relationship study on BTK inhibitors by modified multivariate adaptive regression spline and CoMSIA methods.
    Xu A; Zhang Y; Ran T; Liu H; Lu S; Xu J; Xiong X; Jiang Y; Lu T; Chen Y
    SAR QSAR Environ Res; 2015; 26(4):279-300. PubMed ID: 25906044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 3D QSAR and molecular docking studies of benzimidazole derivatives as hepatitis C virus NS5B polymerase inhibitors.
    Patel PD; Patel MR; Kaushik-Basu N; Talele TT
    J Chem Inf Model; 2008 Jan; 48(1):42-55. PubMed ID: 18076152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular modeling studies on benzimidazole carboxamide derivatives as PARP-1 inhibitors using 3D-QSAR and docking.
    Zeng H; Zhang H; Jang F; Zhao L; Zhang J
    Chem Biol Drug Des; 2011 Sep; 78(3):333-52. PubMed ID: 21585709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.